Geo
Published Jul 28, 2026Updated Jul 30 Major2
100%
Trump Administration Ends Medicare Drug Subsidy, Affecting 25 Million Seniors
The Trump administration is ending a temporary Medicare drug subsidy program that will take effect in 2027, potentially raising prescription costs for approximately 25 million seniors. Beneficiaries could see monthly premium increases ranging from less than $10 to $11–$20, with enrollment rate changes announced in the fall during the midterm election period.
Quick Facts
- Trump administration announces end of Medicare drug subsidy program
- Program to conclude in 2027
- Subsidies offset monthly premiums for Medicare Part D prescription drug coverage
- Federal officials project varied premium impacts across beneficiary population
- Trump administration
The Trump administration announced this week that it will end a temporary Medicare drug subsidy program starting in 2027, a decision that could increase prescription costs for millions of older adults. The subsidy program, initially implemented by the Biden administration in 2024 as part of the Inflation Reduction Act, has helped offset monthly premiums for Medicare Part D prescription drug coverage. The program cost approximately $3.6 billion in 2026.
Approximately 25 million Americans have Medicare Part D plans. In 2026, beneficiaries paid an average of $36 per month in premiums, with subsidies offsetting an average of $16 monthly. According to Trump administration officials, the projected impact varies: 25 percent of enrollees will see no premium change, 30 percent will experience increases of less than $10 monthly, and 45 percent will face increases between $11 and $20 per month. CMS Administrator Dr. Mehmet Oz stated that most beneficiaries would see less than a $10 monthly increase and that low-cost plans would remain available.
The timing of the announcement draws political attention: Medicare beneficiaries will learn their 2027 rates in the fall, coinciding with November's midterm elections. Cost of living has been identified as a top voter concern, and older adults—who tend to vote in high numbers and often live on fixed incomes—represent a significant electoral demographic. Democrats criticized the decision as part of a broader effort to cut healthcare affordability. Senate Minority Leader Chuck Schumer called it "heartless, cruel, and completely by choice."
Trump administration officials told The Wall Street Journal that the subsidies had encouraged insurers to raise rates and that other measures, including existing affordable plan options, would help keep premiums low. The administration noted it has already implemented price increases for some 700 prescription drugs covered under Part D plans. CMS indicated it would release detailed information about 2027 premiums in September, allowing beneficiaries to shop for alternative plans during the open enrollment period.
Why This Matters
Approximately 25 million Medicare Part D beneficiaries face measurable cost changes beginning in 2027: 30% will see monthly increases under $10, while 45% will experience increases of $11–$20. The subsidy program currently costs $3.6 billion annually and has offset an average of $16 monthly per beneficiary. The announcement timing—with 2027 premium notifications scheduled for fall 2026—coincides with the U.S. midterm election cycle, when healthcare affordability ranks as a leading voter concern among older adults, who represent a significant electoral demographic.
Timeline & Sources
Jan 1, 2024
WireBiden administration implements temporary Medicare Part D drug subsidy program as part of Inflation Reduction Act
Jan 1, 2026
WireSubsidy program currently in effect; average monthly premium $36 with $16 average subsidy offset; program costs $3.6 billion
Jul 28, 2026
WireTrump administration announces plans to end Medicare subsidy program (reported by The Wall Street Journal)
Jul 30, 2026
WireCMS formally announces end of subsidy program; CMS Administrator Oz provides rationale
Jan 1, 2027
WireMedicare drug subsidy program ends; new premium rates take effect